As A BABY
Commercial- Indications
- Aesthetic medicine
Company intelligence / Profile preview
Chengdu Shang-Li Aesthetic holds exclusive sales rights in China to high-end injection-use cross-linked sodium hyaluronate gel products from South Korea's Humedix. These have entered clinical registration. The company also develops its own recombinant humanized type III collagen injectables through a joint lab with Zhejiang University International Science and Innovation Center. Its first private label product "As A BABY" has launched commercially. The company covers a range of medical aesthetic injectables including fillers, lipolytic solutions, and supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Shang-Li Aesthetic.